Mass or Gravitationally Induced Neutrino Oscillations? -- A Comparison of \B Neutrino Flux Spectra in a Three--Generation Framework

Both gravitational and mass induced neutrino oscillation mechanisms provide possible resolutions to the Solar Neutrino Problem. The distinguishing feature between the two mechanisms is their dependence on the neutrino energy. We investigate the implications of this by computing the \B neutrino spectrum as determined from each mechanism using a realistic three--flavor evolution model. We find that in the limit of small \tetau mixing angle, the differences are significant enough to observe in future solar neutrino experiments.Comment: 14 pages, latex, epsf, 5 figures; to appear in Phys Lett

Constraints on Exotic Mixing of Three Neutrinos

Exotic explanations are considered for atmospheric neutrino observations. Our analysis includes matter effects and the mixing of all three neutrinos under the simplifying assumption of only one relevant mixing scale. Constraints from accelerator, reactor and solar neutrinos are included. We find that the proposed mixing mechanisms based on violations of Lorentz invariance or on violations of the equivalence principle cannot explain the recent observations of atmospheric neutrino mixing. However the data still allow a wide range of energy dependences for the vacuum mixing scale, and also allow large electron-neutrino mixing of atmospheric neutrinos. Next generation long baseline experiments will constrain these possibilities.Comment: 27 pages, 4 figure

Cost calculation and prediction in adult intensive care: A ground-up utilization study

Publisher's copy made available with the permission of the publisherThe ability of various proxy cost measures, including therapeutic activity scores (TISS and Omega) and cumulative daily severity of illness scores, to predict individual ICU patient costs was assessed in a prospective “ground-up” utilization costing study over a six month period in 1991. Daily activity (TISS and Omega scores) and utilization in consecutive admissions to three adult university associated ICUs was recorded by dedicated data collectors. Cost prediction used linear regression with determination (80%) and validation (20%) data sets. The cohort, 1333 patients, had a mean (SD) age 57.5 (19.4) years, (41% female) and admission APACHE III score of 58 (27). ICU length of stay and mortality were 3.9 (6.1) days and 17.6% respectively. Mean total TISS and Omega scores were 117 (157) and 72 (113) respectively. Mean patient costs per ICU episode (1991 $AUS) were$6801 ($10311), with median costs of$2534, range $106 to$95,602. Dominant cost fractions were nursing 43.3% and overheads 16.9%. Inflation adjusted year 2002 (mean) costs were $9343 ($ AUS). Total costs in survivors were predicted by Omega score, summed APACHE III score and ICU length of stay; determination R2, 0.91; validation 0.88. Omega was the preferred activity score. Without the Omega score, predictors were age, summed APACHE III score and ICU length of stay; determination R2, 0.73; validation 0.73. In non-survivors, predictors were age and ICU length of stay (plus interaction), and Omega score (determination R2, 0.97; validation 0.91). Patient costs may be predicted by a combination of ICU activity indices and severity scores.J. L. Moran, A. R. Peisach, P. J. Solomon, J. Martinhttp://www.aaic.net.au/Article.asp?D=200403

Absence of day-night asymmetry of 862 keV Be-7 solar neutrino rate in Borexino and MSW oscillation parameters

We report on a search for the day-night asymmetry of the Be-7 solar neutrino rate measured by Borexino at the Laboratori Nazionali del Gran Sasso (LNGS), Italy. The measured value, Adn=0.001 +- 0.012 (stat) +- 0.007 (syst), shows the absence of a significant asymmetry. This result alone rejects the so-called LOW solution at more than 8.5 sigma. Combined with the other solar neutrino data, it isolates the Large Mixing Angle (LMA) -- MSW solution at DeltaChi2 > 190 without relying on the assumption of CPT symmetry in the neutrino sector. We also show that including the day-night asymmetry, data from Borexino alone restricts the MSW neutrino oscillations to the LMA solution at 90% confidence level.Comment: 5 figures, published on Phys. Lett

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362